217 related articles for article (PubMed ID: 9475152)
1. Single-agent therapy for nonmetastatic and low-risk gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1998 Jan; 43(1):69-74. PubMed ID: 9475152
[TBL] [Abstract][Full Text] [Related]
2. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
3. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy.
Roberts JP; Lurain JR
Am J Obstet Gynecol; 1996 Jun; 174(6):1917-23; discussion 1923-4. PubMed ID: 8678159
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of gestational trophoblastic disease at a single institute.
Alici S; Eralp Y; Saip P; Argon A; Basaran M; Topuz E; Aydiner A
Tohoku J Exp Med; 2002 Jun; 197(2):95-100. PubMed ID: 12233789
[TBL] [Abstract][Full Text] [Related]
5. Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use.
Kohorn EI
J Reprod Med; 1991 Jan; 36(1):49-55. PubMed ID: 1848901
[TBL] [Abstract][Full Text] [Related]
6. The assessment of value of transvaginal ultrasound for monitoring of gestational trophoblastic disease treatment.
BidziƱski M; Lemieszczuk B; Drabik M
Eur J Gynaecol Oncol; 1997; 18(6):541-3. PubMed ID: 9443032
[TBL] [Abstract][Full Text] [Related]
7. The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D.
Soto-Wright V; Goldstein DP; Bernstein MR; Berkowitz RS
Gynecol Oncol; 1997 Jan; 64(1):156-9. PubMed ID: 8995566
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
Taran A; Ignatov A; Smith B; Bischoff J; Costa SD
Am J Obstet Gynecol; 2008 Nov; 199(5):e6-8. PubMed ID: 18984073
[TBL] [Abstract][Full Text] [Related]
9. Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.
Lurain JR; Chapman-Davis E; Hoekstra AV; Schink JC
J Reprod Med; 2012; 57(7-8):283-7. PubMed ID: 22838241
[TBL] [Abstract][Full Text] [Related]
10. Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy.
Chapman-Davis E; Hoekstra AV; Rademaker AW; Schink JC; Lurain JR
Gynecol Oncol; 2012 Jun; 125(3):572-5. PubMed ID: 22449733
[TBL] [Abstract][Full Text] [Related]
11. Treatment of gestational trophoblastic tumors.
Lurain JR
Curr Treat Options Oncol; 2002 Apr; 3(2):113-24. PubMed ID: 12057074
[TBL] [Abstract][Full Text] [Related]
12. Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy.
Goldstein DP; Zanten-Przybysz IV; Bernstein MR; Berkowitz RS
J Reprod Med; 1998 Jan; 43(1):37-43. PubMed ID: 9475148
[TBL] [Abstract][Full Text] [Related]
13. Management of low-risk metastatic gestational trophoblastic tumors.
DuBeshter B; Berkowitz RS; Goldstein DP; Bernstein MR
J Reprod Med; 1991 Jan; 36(1):36-9. PubMed ID: 1848898
[TBL] [Abstract][Full Text] [Related]
14. Nonmetastatic and low-risk metastatic gestational trophoblastic neoplasms.
Goldstein DP; Berkowitz RS
Semin Oncol; 1982 Jun; 9(2):191-7. PubMed ID: 6289462
[No Abstract] [Full Text] [Related]
15. Comparison of pulsed actinomycin D versus 5-day methotrexate for the treatment of low-risk gestational trophoblastic disease.
Mousavi A; Cheraghi F; Yarandi F; Gilani MM; Shojaei H
Int J Gynaecol Obstet; 2012 Jan; 116(1):39-42. PubMed ID: 21996593
[TBL] [Abstract][Full Text] [Related]
16. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339
[TBL] [Abstract][Full Text] [Related]
17. Alternating methotrexate and dactinomycin in nonmetastatic gestational trophoblastic disease.
Rose PG; Piver MS
J Surg Oncol; 1989 Jul; 41(3):148-52. PubMed ID: 2545973
[TBL] [Abstract][Full Text] [Related]
18. Pulse methotrexate versus pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia.
Yarandi F; Eftekhar Z; Shojaei H; Kanani S; Sharifi A; Hanjani P
Int J Gynaecol Obstet; 2008 Oct; 103(1):33-7. PubMed ID: 18632105
[TBL] [Abstract][Full Text] [Related]
19. Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate--folinic acid.
Smith EB; Weed JC; Tyrey L; Hammond CB
Am J Obstet Gynecol; 1982 Sep; 144(1):88-92. PubMed ID: 6287843
[TBL] [Abstract][Full Text] [Related]
20. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
Lurain JR; Brewer JI
Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]